Priya Singhal, Head of Research & Development at Larimar Therapeutics, holds ― shares in Larimar Therapeutics (Ticker: LRMR), holds 4.89K shares in Biogen (Ticker: BIIB). Most recently, Priya Singhal ― shares of Larimar Therapeutics on ― for an estimated value of ―.